UK Parkinson's Disease Consortium - UKPDC
Bookmark and Share
Feed icon


Prof John Hardy

Prof John Hardy is the first UK winner of $3m Breakthrough Prize in Life Sciences

Professor John Hardy (UCL Institute of Neurology) has been awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease. More...

John Hardy, PhD, right, accepted the 2015 Robert A. Pritzker Prize from MJFF VP Brian Fiske, PhD, and Michael J. Fox on April 15.

John Hardy awarded 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research

One of the UK Parkinson's Disease Consortium Principal Investigators, Prof John Hardy, has been awarded the 2015 Robert A. Pritzker Prize for his leadership in Parkinson's genetics research. The award was presented by Michael J. Fox at a ceremony in New York on April 15. From the Michael J. Fox Foundation website: More...

Webcast - Prof Nicholas Wood - Advances in Genetic Understanding of Parkinson's Disease.

Video: Advances in Genetic Understanding of Parkinson's Disease

Webcast of the presentation entitled ‘Advances in Genetic Understanding of Parkinson's Disease’ given by Nicholas Wood (University College London, United Kingdom) presented at the Biochemical Society Hot Topic event, PINK1-Parkin Signalling in Parkinson’s Disease and Beyond, held in December 2014. More...

Pedigrees and I-FP-CIT SPECT scan images of the four families with GCH1 mutations involved in this study.

GCH1 gene and Parkinson's risk

A study published in Brain, led by researchers at UCL Institute of Neurology, has shown that genetic mutations which cause a decrease in dopamine production in the brain and lead to a form of childhood-onset Dystonia, also play a role in the development of Parkinson’s disease.

Leonard Wolfson Experimental Neurology Centre (LWENC)

The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials


Department of Clinical Genetics, VUMC

Academic programmes, training and research are for the benefit of patients. They profit from the special diagnostics and specific treatments that are available at the VU University Medical Center.

It is for this reason that many patients are referred to the VU University Medical Center by other hospitals. More than half of all patients come from outside Amsterdam. This partly explains the Center’s efforts to adopt an increasingly multidisciplinary approach to care. In this way, consultation, diagnosis, treatment and result can be completed, as far as possible, in a single visit to the clinic or outpatients department. It leads to a greater focus on the individual to be treated, both as a patient and as a person.

The Department of Clinical Genetics is divided into Outpatient's Clinic, Community Genetics, Functional Genome Analysis, Genome Diagnostics, Medical Genome Analysis and Oncogenetics.


Page last modified on 17 mar 11 16:31